Teva Settles Propofol Lawsuits for $250 Million
Teva Pharmaceuticals Industries Ltd. has agreed to pay more than $250 million to settle more than 80 dangerous drug lawsuits claiming the drug manufacturer sold Propofol in a manner that led to colonoscopy patients developing hepatitis C.
According to Bloomberg, the patients had alleged that Teva intentionally sold the anesthetic in large vials to encourage medical professionals to reuse them, even though doing so could increase the risk of spreading blood-borne illnesses such as hepatitis.
Teva faced a number of multi-million dollar jury verdicts, including one that was $500 million and another that surpassed $162 million. The settlement resolves most of the complaints over Propofol.
If you or a loved one has been harmed by a dangerous drug, you may be entitled to compensation. Contact Sokolove Law for a free legal consultation and to learn about your options.